Scinovex
reviewTop 1% cited

PI3K and cancer: lessons, challenges and opportunities

Nature Reviews Drug Discovery · 2014 · Vol. 13(2) · pp. 140–156
David A. FrumanChristian Rommel
Chronic Lymphocytic Leukemia ResearchPI3K/AKT/mTOR signaling in cancerImmunodeficiency and Autoimmune DisordersPI3K/AKT/mTOR pathwayProtein kinase BCancerDiscovery and development of mTOR inhibitorsCancer researchKinaseComputational biologyBiologyMedicineSignal transduction

MeSH terms

Phosphoinositide-3 Kinase InhibitorsAnimalsAntineoplastic AgentsClinical Trials as TopicEnzyme InhibitorsHumansNeoplasmsSignal TransductionReceptor Cross-TalkProto-Oncogene Proteins c-aktDrug DiscoveryTOR Serine-Threonine Kinases
Citations
1,716
FWCI
102.41
field-weighted impact
References
232
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.